APOA5 Antikörper (AA 99-217)
Kurzübersicht für APOA5 Antikörper (AA 99-217) (ABIN7877293)
Target
Alle APOA5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 99-217
-
Verwendungszweck
- APOA5 Antibody / Apolipoprotein A-V
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- Recombinant human protein (amino acids E99-A217) was used as the immunogen for the APOA5 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the APOA5 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the APOA5 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- APOA5 (Apolipoprotein A-V (APOA5))
-
Andere Bezeichnung
- APOA5
-
Hintergrund
- Apolipoprotein A-V is a protein that in humans is encoded by the APOA5 gene. The protein encoded by this gene is an apolipoprotein that plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. Mutations in this gene have been associated with hypertriglyceridemia and hyperlipoproteinemia type 5. This gene is located proximal to the apolipoprotein gene cluster on chromosome 11q23. Alternatively spliced transcript variants encoding the same protein have been identified.
-
UniProt
- Q6Q788
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
Target
-